Silgan Holdings Inc. (SLGN) Key Metrics
SLGN valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $3.99B
- Enterprise value
- $8.41B
- P/E (TTM)
- 14.8 10-yr median 15.9
- Forward P/E
- 8.8
- PEG ratio
- 0.84
- Price / sales
- 0.6 10-yr median 0.8
- Price / book
- 1.7 10-yr median 3.2
- EV / EBITDA
- 9.3 10-yr median 10.1
- Dividend yield
- 2.22% $0.84 a year
- Beta
- 0.67
SLGN key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsSLGN valuation Price multiples at each fiscal year-end price.
SLGN returns How much profit the business earns on the capital it uses.
SLGN per-share figures Results divided by the shares outstanding at year-end.
SLGN financial health Debt, liquidity and how easily interest is covered.
SLGN efficiency & capital use Working capital cycle and where the cash goes.
SLGN valuation history
SLGN returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
SLGN debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
SLGN cash returned to shareholders
SLGN price vs earnings per share
SLGN key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $4.31B | $5.57B | $4.94B | $5.76B | $4.76B | $4.13B | $3.47B | $2.64B | $3.27B | $3.08B |
| Enterprise value | $7.85B | $9.11B | $7.96B | $8.81B | $8.17B | $7.19B | $5.51B | $4.87B | $5.77B | $4.62B |
| P/E ratio | 14.9 | 20.2 | 76.8 | 16.9 | 13.3 | 13.4 | 17.9 | 11.8 | 12.1 | 20.1 |
| Price / sales | 0.7 | 1.0 | 0.8 | 0.9 | 0.8 | 0.8 | 0.8 | 0.6 | 0.8 | 0.9 |
| Price / book | 1.9 | 2.8 | 2.6 | 3.3 | 3.0 | 3.3 | 3.4 | 3.0 | 4.3 | 6.6 |
| Price / free cash flow | 10.2 | 12.1 | 19.3 | 10.8 | 14.7 | 10.9 | 12.5 | 8.4 | 15.2 | 15.2 |
| Price / operating cash flow | 5.9 | 7.7 | 10.2 | 7.7 | 8.6 | 6.9 | 6.8 | 5.2 | 8.4 | 7.8 |
| EV / sales | 1.2 | 1.6 | 1.3 | 1.4 | 1.4 | 1.5 | 1.2 | 1.1 | 1.4 | 1.3 |
| EV / EBITDA | 8.6 | 11.5 | 65.3 | 10.2 | 9.9 | 9.8 | 9.8 | 8.1 | 11.0 | 10.4 |
| EV / free cash flow | 18.6 | 19.8 | 31.1 | 16.5 | 25.2 | 19.0 | 19.9 | 15.4 | 26.8 | 22.8 |
| Earnings yield | 6.7% | 5.0% | 1.3% | 5.9% | 7.5% | 7.5% | 5.6% | 8.5% | 8.2% | 5.0% |
| Free cash flow yield | 9.8% | 8.2% | 5.2% | 9.3% | 6.8% | 9.2% | 8.0% | 12.0% | 6.6% | 6.6% |
| Dividend yield | 2.0% | 1.5% | 1.6% | 1.2% | 1.3% | 1.3% | 1.5% | 1.7% | 1.2% | 1.3% |
| Shareholder yield (dividends + buybacks) | 3.7% | 1.6% | 5.3% | 2.0% | 1.5% | 2.2% | 1.8% | 2.0% | 1.4% | 10.4% |
| Share price at fiscal year-end | $40.37 | $52.05 | $45.25 | $51.84 | $42.84 | $37.08 | $31.08 | $23.62 | $29.39 | $25.59 |
| Per share | ||||||||||
| Revenue per share | $60.71 | $54.67 | $54.82 | $57.75 | $51.07 | $44.19 | $40.27 | $39.85 | $36.73 | $29.98 |
| Earnings per share | $2.70 | $2.58 | $0.59 | $3.07 | $3.23 | $2.77 | $1.74 | $2.01 | $2.42 | $1.27 |
| Operating cash flow per share | $6.83 | $6.74 | $4.42 | $6.74 | $5.01 | $5.41 | $4.55 | $4.54 | $3.50 | $3.27 |
| Free cash flow per share | $3.96 | $4.29 | $2.34 | $4.80 | $2.92 | $3.40 | $2.48 | $2.83 | $1.93 | $1.68 |
| Cash per share | $10.12 | $7.68 | $5.89 | $5.27 | $5.68 | $3.68 | $1.83 | $0.65 | $0.48 | $0.20 |
| Book value per share | $21.30 | $18.58 | $17.30 | $15.48 | $14.06 | $11.25 | $9.18 | $7.89 | $6.88 | $3.90 |
| Tangible book value per share | −$10.42 | −$11.17 | −$7.78 | −$9.28 | −$11.75 | −$10.11 | −$4.25 | −$5.83 | −$7.39 | −$2.62 |
| Dividends per share | $0.80 | $0.77 | $0.72 | $0.65 | $0.56 | $0.48 | $0.46 | $0.40 | $0.36 | $0.34 |
| Capex per share | $2.88 | $2.45 | $2.08 | $1.94 | $2.09 | $2.01 | $2.07 | $1.71 | $1.57 | $1.59 |
| Debt per share | $43.24 | $40.68 | $33.51 | $32.78 | $36.29 | $31.12 | $20.13 | $20.64 | $22.87 | $12.96 |
| Shares outstanding | 106.8M | 107.1M | 109.2M | 111.0M | 111.2M | 111.4M | 111.5M | 111.6M | 111.4M | 120.5M |
| Change in shares outstanding | −0.3% | −2.0% | −1.6% | −0.1% | −0.2% | −0.1% | −0.1% | +0.2% | −7.6% | −1.7% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 13.5% | 14.3% | 3.6% | 20.8% | 25.5% | 27.1% | 20.4% | 27.2% | 43.7% | 27.7% |
| Return on invested capital (ROIC) | 8.1% | 8.7% | 1.9% | 8.9% | 9.6% | 10.5% | 8.9% | 9.9% | 13.6% | 9.8% |
| Return on assets (ROA) | 3.2% | 3.4% | 0.9% | 4.5% | 5.0% | 5.4% | 4.1% | 4.9% | 6.9% | 4.8% |
| Return on tangible assets | 4.8% | 5.1% | 1.3% | 7.4% | 7.3% | 7.5% | 5.6% | 7.4% | 8.8% | 6.5% |
| Free cash flow margin | 6.5% | 7.8% | 4.3% | 8.3% | 5.7% | 7.7% | 6.2% | 7.1% | 5.3% | 5.6% |
| Income quality (OCF / net income) | 2.53 | 2.61 | 7.49 | 2.20 | 1.55 | 1.95 | 2.62 | 2.26 | 1.45 | 2.57 |
| Financial health | ||||||||||
| Total debt | $4.62B | $4.36B | $3.66B | $3.64B | $4.03B | $3.47B | $2.24B | $2.30B | $2.55B | $1.56B |
| Cash & short-term investments | $1.08B | $822.9M | $642.9M | $585.6M | $631.4M | $409.5M | $203.8M | $72.8M | $53.5M | $24.7M |
| Net debt | $3.54B | $3.53B | $3.02B | $3.05B | $3.40B | $3.06B | $2.04B | $2.23B | $2.49B | $1.54B |
| Debt / equity | 2.03 | 2.19 | 1.94 | 2.12 | 2.58 | 2.77 | 2.19 | 2.62 | 3.33 | 3.33 |
| Debt / assets | 0.49 | 0.51 | 0.48 | 0.50 | 0.52 | 0.53 | 0.46 | 0.50 | 0.55 | 0.50 |
| Net debt / EBITDA | 3.86 | 4.47 | 24.73 | 3.54 | 4.12 | 4.19 | 3.62 | 3.71 | 4.76 | 3.47 |
| Current ratio | 1.22 | 1.12 | 1.02 | 1.48 | 1.52 | 1.51 | 1.42 | 1.42 | 1.52 | 1.12 |
| Quick ratio | 0.78 | 0.71 | 0.61 | 0.95 | 0.99 | 0.94 | 0.78 | 0.72 | 0.67 | 0.42 |
| Interest coverage | 3.5 | 3.5 | 2.9 | 4.8 | 5.3 | 4.9 | 3.4 | 3.5 | 3.2 | 4.5 |
| Working capital | $540.0M | $275.2M | $37.1M | $694.8M | $787.3M | $607.6M | $418.0M | $381.2M | $442.5M | $100.4M |
| Invested capital | $5.81B | $5.52B | $4.91B | $4.77B | $4.97B | $4.31B | $3.06B | $3.11B | $3.26B | $2.01B |
| Tangible asset value | −$1.11B | −$1.20B | −$849.9M | −$1.03B | −$1.31B | −$1.13B | −$473.5M | −$650.5M | −$822.4M | −$316.1M |
| Net current asset value | −$4.13B | −$4.07B | −$3.37B | −$3.49B | −$3.91B | −$3.46B | −$2.50B | −$2.41B | −$2.59B | −$1.72B |
| Graham number | $35.98 | $32.84 | $15.15 | $32.69 | $31.96 | $26.48 | $18.94 | $18.88 | $19.36 | $10.56 |
| Graham net-net per share | −$47.38 | −$45.40 | −$38.07 | −$37.50 | −$41.77 | −$36.32 | −$26.98 | −$26.13 | −$28.05 | −$17.74 |
| Capital allocation | ||||||||||
| Dividends paid | $85.8M | $82.1M | $78.9M | $71.9M | $62.5M | $53.6M | $50.8M | $44.5M | $40.5M | $40.9M |
| Share buybacks (net) | $74.9M | $9.3M | $184.0M | $45.1M | $8.6M | $35.9M | $12.1M | $7.8M | $4.1M | $280.7M |
| Dividend payout ratio | 29.7% | 29.7% | 122.5% | 21.1% | 17.4% | 17.4% | 26.2% | 19.9% | 15.0% | 26.7% |
| Dividends + buybacks / free cash flow | 38.0% | 19.9% | 102.8% | 22.0% | 21.9% | 23.7% | 22.8% | 16.6% | 20.7% | 158.7% |
| Capex / revenue | 4.7% | 4.5% | 3.8% | 3.4% | 4.1% | 4.6% | 5.1% | 4.3% | 4.3% | 5.3% |
| Capex / operating cash flow | 42.1% | 36.4% | 47.0% | 28.8% | 41.7% | 37.2% | 45.5% | 37.7% | 44.8% | 48.6% |
| Capex / depreciation | 0.96 | 0.95 | 0.86 | 0.80 | 0.91 | 1.00 | 1.10 | 1.00 | 1.00 | 1.34 |
| Stock-based compensation / revenue | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.4% | 0.4% | 0.3% | 0.4% | 0.4% |
| SG&A / revenue | 7.6% | 7.5% | 7.0% | 5.8% | 5.8% | 15.3% | 7.0% | 6.9% | 7.5% | 6.1% |
| Efficiency | ||||||||||
| Days sales outstanding | 33.3 | 37.2 | 38.3 | 39.0 | 42.8 | 41.7 | 41.3 | 39.6 | 33.1 | 28.8 |
| Days of inventory on hand | 68.7 | 70.4 | 278.3 | 53.4 | 56.6 | 59.0 | 61.3 | 65.8 | 69.9 | 72.4 |
| Days payables outstanding | 80.9 | 82.4 | 333.6 | 71.7 | 74.2 | 68.8 | 69.6 | 66.6 | 61.5 | 57.8 |
| Cash conversion cycle (days) | 21.2 | 25.2 | -17.0 | 20.6 | 25.2 | 31.8 | 33.0 | 38.8 | 41.6 | 43.4 |
| Receivables turnover | 10.95 | 9.81 | 9.52 | 9.36 | 8.53 | 8.75 | 8.84 | 9.21 | 11.01 | 12.69 |
| Payables turnover | 4.51 | 4.43 | 1.09 | 5.09 | 4.92 | 5.30 | 5.25 | 5.48 | 5.93 | 6.32 |
| Inventory turnover | 5.31 | 5.18 | 1.31 | 6.84 | 6.45 | 6.19 | 5.96 | 5.54 | 5.22 | 5.04 |
| Asset turnover | 0.72 | 0.72 | 0.80 | 0.85 | 0.79 | 0.86 | 0.94 | 0.97 | 1.05 | 1.14 |
| Average receivables | $591.8M | $596.9M | $628.7M | $684.6M | $665.4M | $562.3M | $508.1M | $483.0M | $371.4M | $284.6M |
| Average payables | $1.18B | $1.09B | $1.02B | $1.05B | $967.9M | $764.8M | $719.9M | $686.2M | $582.2M | $491.0M |
| Average inventory | $1.00B | $934.4M | $855.1M | $784.1M | $738.2M | $655.3M | $633.9M | $678.0M | $662.1M | $615.5M |
| Intangibles / total assets | 36.0% | 37.1% | 36.0% | 37.4% | 36.9% | 36.5% | 30.4% | 33.5% | 34.2% | 24.9% |
Computed from SLGN's annual financial statements (latest annual report filed February 26, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
SLGN valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Silgan traded at 14.9 times earnings, against a 10-year median of 15.9. Based on the latest twelve months, the trailing P/E is 14.8 and the forward P/E is 8.8. Silgan earned a return on equity of 13.5% and a return on invested capital of 8.1% in fiscal 2025. It ended the year with $4.6 billion of debt and $1.1 billion in cash and short-term investments, net debt of $3.5 billion. It returned $160.7 million to shareholders: $85.8 million in dividends and $74.9 million in share buybacks, 38% of free cash flow. The share count fell 11.4% from 120.5M to 106.8M over 9 years.
See the SLGN income statement, the SLGN chart for price history, or the SLGN stock overview for the latest quote and news.
SLGN key metrics FAQ
What is Silgan's P/E ratio?
Silgan's trailing P/E ratio is 14.8 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 8.8. At the end of fiscal 2025 it was 14.9, compared with a 10-year median of 15.9.
What is Silgan's EV/EBITDA?
Silgan's enterprise value was 8.6 times EBITDA at the end of fiscal 2025 (enterprise value $7.8 billion, EBITDA $917.0 million); the current EV/EBITDA is 9.3.
What is Silgan's return on equity?
Silgan's return on equity (ROE) was 13.5% in fiscal 2025: net income of $288.4 million on average shareholders' equity of $2.1 billion.
What is Silgan's ROIC?
Silgan's return on invested capital was 8.1% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Silgan have?
Silgan had total debt of $4.6 billion at the end of fiscal 2025, a debt-to-equity ratio of 2.03 and $3.5 billion of net debt (3.86 times EBITDA).
What is Silgan's dividend yield?
Silgan's forward dividend yield is 2.22%. Silgan paid $85.8 million in dividends in fiscal 2025 ($0.80 per share), a payout ratio of 29.7%.
Does Silgan buy back its shares?
Yes. Silgan spent $74.9 million on net share repurchases in fiscal 2025 Shares outstanding changed −0.3% over the year, to 106.8M..
What is Silgan's free cash flow yield?
Silgan generated $422.7 million of free cash flow in fiscal 2025, a free cash flow yield of 9.8% on its market value at year-end ($4.3 billion).
What is Silgan's current ratio?
Silgan's current ratio was 1.22 at the end of fiscal 2025: current assets were 1.22 times current liabilities.